Emory University — Biomedical Watch V2

Essais liés35clinical trials

VilleAtlantalocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07517263

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
Percutaneous Mechanical Circulatory Support	Maladie coronarienne	Non applicable	NCT06445608	PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm	RECRUITING
BrioVAD System	Insuffisance cardiaque	Non applicable	NCT06310031	INNOVATE — Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure	ACTIVE_NOT_RECRUITING
High dose potent statin	Maladie coronarienne	Phase 4	NCT03417388	WARRIOR — Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD	ACTIVE_NOT_RECRUITING
brexucabtagene autoleucel	SEP	Phase 1	NCT03624036	ZUMA-8 — Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma	TERMINATED
isunakinra	Cancer	Phase 2	NCT06634875	Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)	RECRUITING
Empagliflozin	Maladie rénale chronique	Phase 3	NCT07107945	A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)	ACTIVE_NOT_RECRUITING
AFSW Guided DOAC	Accident vasculaire cérébral	Phase 3	NCT05836987	REACT-AF — The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	RECRUITING
Pelacarsen (TQJ230)	Accident vasculaire cérébral	Phase 3	NCT07517263	An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)	ACTIVE_NOT_RECRUITING
Rituximab	SEP	Phase 1	NCT03636503	Rituximab + Immunotherapy in Follicular Lymphoma	TERMINATED
RNS System	Épilepsie	Phase 2	NCT05339126	RNS System LGS Feasibility Study	ACTIVE_NOT_RECRUITING
carboplatin	Cancer	Phase 2	NCT04665765	Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma	ACTIVE_NOT_RECRUITING
TUB-040	Cancer	Phase 1/2	NCT06303505	NAPISTAR1-01 — FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC	RECRUITING
GammaCore/electroCore non-invasive VNS device	SEP	Phase 3	NCT02992899	Closed Loop Vagal Nerve Stimulation for Patients With Posttraumatic Stress Disorder	COMPLETED
Baricitinib 4 MG	Alzheimer	Phase 3	NCT05858515	REVERSE-LC — REVERSE-Long COVID-19 With Baricitinib Study	WITHDRAWN
Low Dose Mesenchymal Stem Cells (MSCs)	Lupus	Phase 2	NCT02633163	Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)	COMPLETED
CABA-201	Lupus	Phase 1/2	NCT06121297	RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus	RECRUITING
NEU-411	Parkinson	Phase 2	NCT06680830	NEULARK — A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease	RECRUITING
Ketamine	Épilepsie	Phase 2	NCT07768618	Ketamine-sEEG — Electrophysiologic Mechanisms of Ketamine Antidepressant Response	NOT_YET_RECRUITING
Tofersen	Sclérose latérale amyotrophique	Phase 2	NCT07294144	Tofersen in Non-SOD1 ALS	RECRUITING
Adult and Juvenile Myositis	Myopathies	À vérifier	NCT00017914	Adult and Juvenile Myositis	RECRUITING
Solanezumab	Alzheimer	Phase 3	NCT02008357	A4 — Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss	COMPLETED
Neuraceq	Alzheimer	À vérifier	NCT05617014	ADNI4 — Alzheimer's Disease Neuroimaging Initiative 4	ENROLLING_BY_INVITATION
Ianalumab	Lupus	Phase 3	NCT05624749	Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)	ACTIVE_NOT_RECRUITING
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)	Sclérose latérale amyotrophique	À vérifier	NCT04363684	ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)	RECRUITING
COYA 302	Sclérose latérale amyotrophique	Phase 2/3	NCT07161999	ALSTARS — Study of COYA 302 for the Treatment of ALS	ACTIVE_NOT_RECRUITING
RE104 for Injection	Sclérose latérale amyotrophique	Phase 2	NCT07002034	RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	RECRUITING
Pridopidine	Sclérose latérale amyotrophique	Phase 3	NCT07322003	PREVAiLS — Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS	RECRUITING
PF-06823859	Lupus	Phase 2	NCT05879718	A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.	TERMINATED
extended release metformin	Alzheimer	Phase 2/3	NCT04098666	MAP — Metformin in Alzheimer's Dementia Prevention	ACTIVE_NOT_RECRUITING
Transcutaneous Cervical Vagal Nerve Stimulation	SEP	Phase 3	NCT05834478	VNS in OUD UH3 — Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3	RECRUITING
Anti-hypertensive therapy	Hypertension	Phase 4	NCT02299414	Chronic Hypertension and Pregnancy (CHAP) Project	COMPLETED
ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	Alzheimer	À vérifier	NCT01078636	ADNI-GO — Alzheimer's Disease Neuroimaging Initiative Grand Opportunity	COMPLETED
Low Dose Mesenchymal Stem Cells (MSCs)	Lupus	Phase 1	NCT03171194	Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus	COMPLETED
eculizumab	Myasthénie	Phase 2	NCT00727194	Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis	TERMINATED
RNS® System	Épilepsie	Phase 4	NCT00572195	RNS® System LTT Study	COMPLETED